WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2008

Feb 28, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-02-26

Reporting Person: HARGESHEIMER ROBERT S (President-The Tech Group)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-02-26	Common Stock	A	3693	$41.7	Acquired	15308.3612	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-02-26	Stock Option (Right to Buy)	$41.7	A	13749	Acquired	2018-02-26	Common Stock (13749)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4814.8618	Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period IV.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.